Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Growth factor signals influence balance between normal growth and cancerous growth

Protein interactions suggest potential cancer risks, but also potential cancer therapies

For many biological processes, the Goldilocks Principle rules. You don't want too much, or too little, of something, you want it just right.

So it is with the body's delicate concentration of growth factors. Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis, among other problems.

New research from The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine deepens the understanding of how the growth hormone/IGF system is affected by another important actor: p53, the tumor suppressor gene that puts the brakes on cancer. The interplay of the two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone and IGF-I to patients, at the same time that it may suggest a future new avenue for cancer therapy.

... more about:
»Grimberg »IGF »IGF-I »factor »p53

The study, which used cell cultures and mice, was published in the October issue of Cancer Biology & Therapy.

"It was already known that the tumor suppressor protein p53, which causes a cell to stop growing or to self-destruct, also acts on genes in the growth hormone/IGF axis to turn down IGF signaling," said pediatric endocrinologist and lead author Adda Grimberg, M.D., of The Children's Hospital of Philadelphia. "In this paper we showed that p53 increases production of insulin-like growth factor binding protein-2, an interaction that was not previously known." That protein, abbreviated as IGFBP-2, binds to IGF-I, and thus makes the growth factor less available to act on the body's tissues.

When the authors used genes to halt IGFBP-2 production by prostate cancer cells in culture, they found that p53 lost its ability to block IGF-I from activating one of its major signaling targets in those cells.

IGF-I is important because, along with naturally produced human growth hormone, it is the major regulator of body growth during childhood. These hormones continue to have important health effects during adulthood, after growth is done.

IGF-I is also of considerable interest to cancer researchers, because of mounting evidence that high levels of the protein contribute to cancer risk. One of the study's co-authors, oncologist Wafik El-Deiry, M.D., Ph.D., of the University of Pennsylvania, is internationally prominent for his studies of the p53 protein. "This work provides a novel and important insight into the regulation of growth by the major tumor suppressor p53," Dr El-Deiry said. He added, "For years we've known that p53 regulates another binding protein, IGBFP-3, to inhibit IGF signaling, but now we know that was the tip of the iceberg, as p53 appears to regulate the IGF axis at multiple nodes. It took collaboration between an endocrinologist and a medical oncologist to break this new ground, which has impact on both fields."

"We have no evidence now that either growth hormone or IGF-I actually causes cancer, but IGF-I may contribute to cancer progression and aggressiveness," said Dr. Grimberg. "IGF-I doesn't ignite the fire; it fuels it." At each stage that cancer progresses, she added, "IGF signaling can stimulate cells to behave more dangerously."

The study may have implications for patients receiving growth hormone or other growth-promoting therapies. Recombinant human growth hormone has been prescribed for the past 21 years for children with deficiency of normal growth hormone, to avoid abnormally short stature. However, in a controversial usage, that growth hormone is also prescribed for some short but healthy children with normal IGF-I levels to increase their height. "Excess levels of growth hormone and IGF-I may have long-term health risks," said Dr. Grimberg. "This study shows the interactions among pathways affecting growth and cancer are more complex than we have previously appreciated."

Better understanding of those complexities may have eventual clinical benefits as well, added Dr. Grimberg. "Understanding the fine-tuning of the growth hormone/IGF system at the cellular level may also lead to novel therapies for cancer. If we can develop drugs to safely inhibit IGF signaling, these may improve the effectiveness of conventional anti-cancer treatments such as chemotherapy and radiation."

John Ascenzi | EurekAlert!
Further information:

Further reports about: Grimberg IGF IGF-I factor p53

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>